Lab supplies cardinal health 414, LLC:1109813 [20-000014]
Ended Awarded Last action
- Contract number
- 75N90020F00001
- Awardee
-
Cardinal Health 414, LLC UEI CWN9UGL3NCL9 Part of Cardinal Health, Inc.
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,919
Award facts
- Opportunity
-
- NIHP160018F Solicitation number
- F-18 FDG Unit Doses in Shielded Delivery and Administration Containers Award Notice · Posted May 16, 2016
- Contract value 100% obligated
- $9,919.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$981 | |
| Original award | $10,900 |
About this award
This contract award represents an administrative de-obligation action by the National Institutes of Health Clinical Center to close out unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with a ceiling value of $9,919.00. The award was issued to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. specializing in the manufacturing, testing, and distribution of radiopharmaceuticals and medical isotopes to federal healthcare agencies. The delivery order, executed on October 31, 2019, with an ultimate completion date of September 30, 2020, was structured as a firm fixed-price contract with no set-aside designation, and specified performance at Cardinal Health 414's primary facility in Dublin, Ohio.
Cardinal Health 414 serves as a critical supplier of nuclear medicine and diagnostic imaging products essential for oncology treatment and diagnostic procedures across the federal healthcare infrastructure. The company maintains extensive Indefinite Delivery Contracts and Blanket Purchase Agreements with numerous Veterans Integrated Service Networks and the Defense Health Agency, with established supply relationships extending through 2029 and 2030. The company's radiopharmaceutical portfolio includes specialized products such as Technetium-99m, Iodine-123, Iodine-131, Indium-111, Thallium-201, and advanced therapeutic agents including Xofigo (radium-223 dichloride) for prostate cancer treatment and Lymphoseek for diagnostic imaging, enabling flexible procurement across multiple federal military treatment facilities and Veterans Affairs medical centers nationwide.
Quick answers
Who was awarded contract 75N90020F00001?
75N90020F00001 was awarded to Cardinal Health 414, LLC by NIH Clinical Center (National Institutes of Health) on October 31, 2019.
How much is contract 75N90020F00001 worth?
The government has obligated $9,919 on 75N90020F00001.
Is contract 75N90020F00001 an order under another contract?
Yes. 75N90020F00001 is a delivery order under HHSN269201600005I, an indefinite delivery contract.
Was contract 75N90020F00001 competed?
The extent of competition for 75N90020F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award